查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1799211

全球远距药事照护市场

Telepharmacy
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 144 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球远距药事照护市场规模将达到 406 亿美元

全球远距药事照护市场规模预计在2024年达到117亿美元，预计在分析期内（2024-2030年）的复合年增长率为23.1%，到2030年将达到406亿美元。病患咨询服务是本报告分析的细分市场之一，预计其复合年增长率为24.6%，到分析期结束时将达到206亿美元。远距药局服务细分市场在分析期间内的复合年增长率预计为23.5%。

美国市场规模估计为 31 亿美元，中国市场预计复合年增长率为 21.8%

美国远距药事照护市场规模预计在2024年达到31亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到62亿美元，在2024-2030年的分析期间内，复合年增长率为21.8%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为21.5%和19.9%。在欧洲，预计德国市场的复合年增长率约为16.9%。

全球远距药事照护市场－主要趋势与驱动因素摘要

远距药事照护如何缩小医疗保健服务的差距？

远距药事照护使配药、咨询和治疗监测等医药服务能够透过数位平台远端交付。药房使用视讯通话、安全通讯和机器人配药单元，为农村和服务不足地区（这些地区缺乏实体药房）的患者提供服务。云端基础的药房管理系统有助于处方笺验证、电子健康记录整合和依从性追踪。从先导计画到全面整合的远距远距药事照护网路的转变，反映了一种新的视角：药局不再只是实体配药房，而是几乎全天候开放的医疗保健服务交付节点。

哪些技术进步推动了这项演变？

人工智慧驱动的药物审查工具正在帮助药剂师识别药物交互作用并进行个人化剂量调整。自动配药亭和远端机械臂使远端技术人员能够在药剂师的监督下监督安全配药。远端药物护理应用程式提供续药提醒、虚拟吞药指导和慢性病生命征象监测等功能。区块链和电子处方笺系统提高了处方笺安全性和互通性，即时翻译模组为医疗资源匮乏地区的非母语人士提供支援。这些创新正在重塑传统的工作流程，从而提供更有效率、更高品质的患者支援。

哪些相关人员的需求推动了远距药事照护的采用？

行动不便或患有慢性疾病的患者受益于宅配和远端咨询，这减轻了出行负担，并提高了服药依从性。雇主和保险公司将远距药事照护视为确保护理连续性并降低急诊就诊相关成本的一种方式。面临劳动力短缺的药房正在利用远距药事照护重新分配药剂师的时间，支援非工作时间服务，并扩大服务覆盖范围。卫生系统和社区医院正在采用远距药事照护来遵守监管要求，在乡村诊所和夜班期间提供电子药物核对，并提高偏远地区患者的安全。

是什么推动了远距药事照护市场的发展？

远距药事照护市场的成长受到多种因素的推动，包括远端配药和电子处方处方笺的放鬆、药房自动化硬体投资的增加、需要持续药物管理的慢性病的盛行，以及患者对便捷虚拟护理的偏好。远端医疗平台与药品福利管理公司 (PBM) 的融合实现了整合服务并增强了依从性追踪。科技公司正在拓展药局服务领域，药师在某些地区也逐渐成为服务提供者。

部分

服务（病患咨询服务、远距药局服务、药物治疗监测服务、处方续药授权服务）；部署（本地部署、基于 Web 的部署、云端基础的部署）

受访公司范例

  • Advanced Rx Management
  • Alto Pharmacy
  • AMN Healthcare
  • Cardinal Health
  • CarepathRx
  • Cisco Systems
  • Comprehensive Pharmacy Services（CPS）
  • Locke Bio
  • McKesson Ventures
  • Medication Review Inc.
  • MedTel Services
  • North West TelePharmacy Solutions
  • Nurx
  • One Touch Video Chat
  • OSP Labs（telepharmacy solutions）
  • PDS（Pharmacy Delivery Systems）
  • PharmD Live
  • PipelineRx
  • Truepill
  • Zane Networks

人工智慧集成

我们正在利用有效的专家内容和人工智慧工具来改变市场和竞争情报。

Global Industry Analysts 没有查询通用的 LLM 或特定产业的SLM，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 比赛

简介目录
Product Code: MCP39415

Global Telepharmacy Market to Reach US$40.6 Billion by 2030

The global market for Telepharmacy estimated at US$11.7 Billion in the year 2024, is expected to reach US$40.6 Billion by 2030, growing at a CAGR of 23.1% over the analysis period 2024-2030. Patient Counseling Services, one of the segments analyzed in the report, is expected to record a 24.6% CAGR and reach US$20.6 Billion by the end of the analysis period. Growth in the Remote Dispensing Services segment is estimated at 23.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.1 Billion While China is Forecast to Grow at 21.8% CAGR

The Telepharmacy market in the U.S. is estimated at US$3.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.2 Billion by the year 2030 trailing a CAGR of 21.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 21.5% and 19.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 16.9% CAGR.

Global Telepharmacy Market - Key Trends & Drivers Summarized

How is Telepharmacy Bridging Gaps in Healthcare Access?

Telepharmacy enables remote delivery of pharmaceutical services-such as medication dispensing, counseling, and therapy monitoring-via digital platforms. Pharmacies use video calls, secure messaging, and robotic dispensing units to serve patients in rural or underserved areas lacking brick-and-mortar pharmacies. Cloud-based pharmacy management systems facilitate prescription verification, electronic health records integration, and adherence tracking. The move from pilot projects to fully integrated telepharmacy networks reflects a shift in how pharmacies are viewed-not just as physical dispensaries, but as healthcare delivery nodes accessible virtually 24/7.

What Technological Advances Are Driving This Evolution?

AI-powered medication review tools now assist pharmacists in identifying drug-drug interactions and personalized dosage adjustments. Automated dispensing kiosks and tele-robotic arms allow remote technicians to oversee safe fulfillment under pharmacist supervision. Tele-pharmaceutical care apps offer features like refill reminders, virtual pill-swallowing coaching, and biometric monitoring for chronic conditions. Blockchain and e-prescription systems improve prescription security and interoperability, while real-time translation modules support non-native speakers in underserved regions. These innovations are reshaping traditional workflow, enabling more efficient, high-quality patient support.

Which Stakeholder Needs Are Steering Telepharmacy Adoption?

Patients with mobility limitations or chronic diseases benefit from home delivery and remote counseling-reducing travel burden and enhancing medication adherence. Employers and insurers see telepharmacy as a way to ensure continuity of care while lowering costs tied to emergency visits. Pharmacies facing workforce shortages leverage telepharmacy to redistribute pharmacist time, support after-hours service, and expand service coverage. Health systems and community hospitals incorporate telepharmacy to comply with regulatory requirements and offer electronic medication reconciliation in rural clinics or during night shifts, improving patient safety in remote settings.

What Is Propelling the Telepharmacy Market Forward?

The growth in the telepharmacy market is driven by several factors including regulatory easing on remote dispensing and e-prescriptions, increased investment in pharmacy automation hardware, rising chronic disease prevalence requiring ongoing medication management, and patient preference for convenient, virtual care. The convergence of telehealth platforms with pharmacy benefit managers (PBMs) enables integrated services and enhanced adherence tracking. Technology companies are expanding into pharmacy services, and pharmacists are gaining provider status in some regions-creating a favorable environment for telepharmacy growth.

SCOPE OF STUDY:

The report analyzes the Telepharmacy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Services (Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services, Refill Authorization for Prescription Drugs Services); Deployment (On-Premise Deployment, Web-based Deployment, Cloud-based Deployment)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Advanced Rx Management
  • Alto Pharmacy
  • AMN Healthcare
  • Cardinal Health
  • CarepathRx
  • Cisco Systems
  • Comprehensive Pharmacy Services (CPS)
  • Locke Bio
  • McKesson Ventures
  • Medication Review Inc.
  • MedTel Services
  • North West TelePharmacy Solutions
  • Nurx
  • One Touch Video Chat
  • OSP Labs (telepharmacy solutions)
  • PDS (Pharmacy Delivery Systems)
  • PharmD Live
  • PipelineRx
  • Truepill
  • Zane Networks

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Telepharmacy - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Medication Access in Remote and Underserved Areas Throws the Spotlight on Telepharmacy
    • Growth in Chronic Disease Management and Medication Adherence Programs Drives Virtual Pharmacy Adoption
    • Integration with EHR and Telemedicine Platforms Strengthens the Business Case for Pharmacist-Led Virtual Consults
    • Post-COVID Acceleration of Digital Health Acceptance Spurs Long-Term Demand for Remote Pharmacy Services
    • Expansion of Mail-Order and E-Prescription Models Enables Seamless Fulfillment Through Telepharmacy Channels
    • Increased Use of Video Counseling and Refill Management Tools Improves Patient Engagement and Compliance
    • Technology Integration with Smart Pill Dispensers and Medication Tracking Apps Expands Ecosystem Reach
    • Rise of D2C Health Startups Creates Strategic Demand for API-Enabled Telepharmacy Infrastructure
    • Growth of Specialty Pharmacy Services Supports Virtual Counseling for Complex Medication Regimens
    • Cost Savings for Healthcare Systems Fuel Adoption of Telepharmacy in Rural and Institutional Settings
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Telepharmacy Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Telepharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Telepharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Patient Counseling Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Patient Counseling Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Remote Dispensing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Remote Dispensing Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Drug Therapy Monitoring Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Drug Therapy Monitoring Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Refill Authorization for Prescription Drugs Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Refill Authorization for Prescription Drugs Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for On-Premise Deployment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for On-Premise Deployment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Web-based Deployment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Web-based Deployment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Cloud-based Deployment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Cloud-based Deployment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Telepharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 18: USA Recent Past, Current & Future Analysis for Telepharmacy by Services - Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 19: USA 6-Year Perspective for Telepharmacy by Services - Percentage Breakdown of Value Sales for Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services for the Years 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Telepharmacy by Deployment - On-Premise Deployment, Web-based Deployment and Cloud-based Deployment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Telepharmacy by Deployment - Percentage Breakdown of Value Sales for On-Premise Deployment, Web-based Deployment and Cloud-based Deployment for the Years 2025 & 2030
  • CANADA
    • TABLE 22: Canada Recent Past, Current & Future Analysis for Telepharmacy by Services - Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 23: Canada 6-Year Perspective for Telepharmacy by Services - Percentage Breakdown of Value Sales for Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services for the Years 2025 & 2030
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Telepharmacy by Deployment - On-Premise Deployment, Web-based Deployment and Cloud-based Deployment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Canada 6-Year Perspective for Telepharmacy by Deployment - Percentage Breakdown of Value Sales for On-Premise Deployment, Web-based Deployment and Cloud-based Deployment for the Years 2025 & 2030
  • JAPAN
    • Telepharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Telepharmacy by Services - Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Japan 6-Year Perspective for Telepharmacy by Services - Percentage Breakdown of Value Sales for Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services for the Years 2025 & 2030
    • TABLE 28: Japan Recent Past, Current & Future Analysis for Telepharmacy by Deployment - On-Premise Deployment, Web-based Deployment and Cloud-based Deployment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Japan 6-Year Perspective for Telepharmacy by Deployment - Percentage Breakdown of Value Sales for On-Premise Deployment, Web-based Deployment and Cloud-based Deployment for the Years 2025 & 2030
  • CHINA
    • Telepharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 30: China Recent Past, Current & Future Analysis for Telepharmacy by Services - Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: China 6-Year Perspective for Telepharmacy by Services - Percentage Breakdown of Value Sales for Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services for the Years 2025 & 2030
    • TABLE 32: China Recent Past, Current & Future Analysis for Telepharmacy by Deployment - On-Premise Deployment, Web-based Deployment and Cloud-based Deployment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: China 6-Year Perspective for Telepharmacy by Deployment - Percentage Breakdown of Value Sales for On-Premise Deployment, Web-based Deployment and Cloud-based Deployment for the Years 2025 & 2030
  • EUROPE
    • Telepharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 34: Europe Recent Past, Current & Future Analysis for Telepharmacy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 35: Europe 6-Year Perspective for Telepharmacy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 36: Europe Recent Past, Current & Future Analysis for Telepharmacy by Services - Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Europe 6-Year Perspective for Telepharmacy by Services - Percentage Breakdown of Value Sales for Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services for the Years 2025 & 2030
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Telepharmacy by Deployment - On-Premise Deployment, Web-based Deployment and Cloud-based Deployment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Europe 6-Year Perspective for Telepharmacy by Deployment - Percentage Breakdown of Value Sales for On-Premise Deployment, Web-based Deployment and Cloud-based Deployment for the Years 2025 & 2030
  • FRANCE
    • Telepharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 40: France Recent Past, Current & Future Analysis for Telepharmacy by Services - Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: France 6-Year Perspective for Telepharmacy by Services - Percentage Breakdown of Value Sales for Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services for the Years 2025 & 2030
    • TABLE 42: France Recent Past, Current & Future Analysis for Telepharmacy by Deployment - On-Premise Deployment, Web-based Deployment and Cloud-based Deployment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: France 6-Year Perspective for Telepharmacy by Deployment - Percentage Breakdown of Value Sales for On-Premise Deployment, Web-based Deployment and Cloud-based Deployment for the Years 2025 & 2030
  • GERMANY
    • Telepharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 44: Germany Recent Past, Current & Future Analysis for Telepharmacy by Services - Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Germany 6-Year Perspective for Telepharmacy by Services - Percentage Breakdown of Value Sales for Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services for the Years 2025 & 2030
    • TABLE 46: Germany Recent Past, Current & Future Analysis for Telepharmacy by Deployment - On-Premise Deployment, Web-based Deployment and Cloud-based Deployment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Germany 6-Year Perspective for Telepharmacy by Deployment - Percentage Breakdown of Value Sales for On-Premise Deployment, Web-based Deployment and Cloud-based Deployment for the Years 2025 & 2030
  • ITALY
    • TABLE 48: Italy Recent Past, Current & Future Analysis for Telepharmacy by Services - Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Italy 6-Year Perspective for Telepharmacy by Services - Percentage Breakdown of Value Sales for Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services for the Years 2025 & 2030
    • TABLE 50: Italy Recent Past, Current & Future Analysis for Telepharmacy by Deployment - On-Premise Deployment, Web-based Deployment and Cloud-based Deployment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Italy 6-Year Perspective for Telepharmacy by Deployment - Percentage Breakdown of Value Sales for On-Premise Deployment, Web-based Deployment and Cloud-based Deployment for the Years 2025 & 2030
  • UNITED KINGDOM
    • Telepharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 52: UK Recent Past, Current & Future Analysis for Telepharmacy by Services - Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: UK 6-Year Perspective for Telepharmacy by Services - Percentage Breakdown of Value Sales for Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services for the Years 2025 & 2030
    • TABLE 54: UK Recent Past, Current & Future Analysis for Telepharmacy by Deployment - On-Premise Deployment, Web-based Deployment and Cloud-based Deployment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: UK 6-Year Perspective for Telepharmacy by Deployment - Percentage Breakdown of Value Sales for On-Premise Deployment, Web-based Deployment and Cloud-based Deployment for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Telepharmacy by Services - Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Rest of Europe 6-Year Perspective for Telepharmacy by Services - Percentage Breakdown of Value Sales for Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services for the Years 2025 & 2030
    • TABLE 58: Rest of Europe Recent Past, Current & Future Analysis for Telepharmacy by Deployment - On-Premise Deployment, Web-based Deployment and Cloud-based Deployment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Rest of Europe 6-Year Perspective for Telepharmacy by Deployment - Percentage Breakdown of Value Sales for On-Premise Deployment, Web-based Deployment and Cloud-based Deployment for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Telepharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 60: Asia-Pacific Recent Past, Current & Future Analysis for Telepharmacy by Services - Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Asia-Pacific 6-Year Perspective for Telepharmacy by Services - Percentage Breakdown of Value Sales for Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services for the Years 2025 & 2030
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Telepharmacy by Deployment - On-Premise Deployment, Web-based Deployment and Cloud-based Deployment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific 6-Year Perspective for Telepharmacy by Deployment - Percentage Breakdown of Value Sales for On-Premise Deployment, Web-based Deployment and Cloud-based Deployment for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 64: Rest of World Recent Past, Current & Future Analysis for Telepharmacy by Services - Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Rest of World 6-Year Perspective for Telepharmacy by Services - Percentage Breakdown of Value Sales for Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services for the Years 2025 & 2030
    • TABLE 66: Rest of World Recent Past, Current & Future Analysis for Telepharmacy by Deployment - On-Premise Deployment, Web-based Deployment and Cloud-based Deployment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Rest of World 6-Year Perspective for Telepharmacy by Deployment - Percentage Breakdown of Value Sales for On-Premise Deployment, Web-based Deployment and Cloud-based Deployment for the Years 2025 & 2030

IV. COMPETITION